To further identify the role of NQO1 in the global changes induced by β-lap treatment, we knocked down NQO1 in high-invasive breast cancer cell lines MCF-7 and MDA-MB-231, then treated cells with β-lap. The gene discussed is NQO1; the disease is breast carcinoma.